This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-125a-3p | CIRBP | 1.24 | 1.0E-5 | -0.68 | 0.00013 | miRanda | -0.13 | 2.0E-5 | NA | |
2 | hsa-miR-24-3p | CIRBP | 1 | 0 | -0.68 | 0.00013 | miRNAWalker2 validate | -0.28 | 0 | NA | |
3 | hsa-miR-338-5p | CIRBP | -0.58 | 0.04722 | -0.68 | 0.00013 | MirTarget; PITA; miRNATAP | -0.14 | 0 | NA | |
4 | hsa-miR-590-3p | CIRBP | 2.59 | 0 | -0.68 | 0.00013 | miRanda | -0.14 | 0 | NA | |
5 | hsa-miR-590-5p | CIRBP | 3.18 | 0 | -0.68 | 0.00013 | miRanda | -0.1 | 0.00028 | NA | |
6 | hsa-miR-629-3p | CIRBP | 2.37 | 0 | -0.68 | 0.00013 | mirMAP | -0.17 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA PROCESSING | 48 | 835 | 2.898e-25 | 1.348e-21 |
2 | MRNA METABOLIC PROCESS | 40 | 611 | 4.725e-23 | 1.099e-19 |
3 | RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 28 | 267 | 1.045e-21 | 1.62e-18 |
4 | MRNA PROCESSING | 33 | 432 | 4.098e-21 | 4.767e-18 |
5 | RNA SPLICING | 30 | 367 | 4.465e-20 | 4.156e-17 |
6 | RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 27 | 440 | 5.076e-15 | 3.936e-12 |
7 | NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 9 | 22 | 1.656e-13 | 1.101e-10 |
8 | NUCLEAR IMPORT | 14 | 129 | 1.363e-11 | 7.93e-09 |
9 | PROTEIN FOLDING | 17 | 224 | 2.737e-11 | 1.415e-08 |
10 | PROTEIN IMPORT | 14 | 155 | 1.646e-10 | 7.588e-08 |
11 | PROTEIN LOCALIZATION TO NUCLEUS | 14 | 156 | 1.794e-10 | 7.588e-08 |
12 | NUCLEAR TRANSPORT | 19 | 355 | 7.236e-10 | 2.806e-07 |
13 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 21 | 448 | 9.725e-10 | 3.481e-07 |
14 | MITOTIC CELL CYCLE | 27 | 766 | 1.842e-09 | 6.122e-07 |
15 | REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 6 | 15 | 2.527e-09 | 7.348e-07 |
16 | POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 6 | 15 | 2.527e-09 | 7.348e-07 |
17 | CELL CYCLE G1 S PHASE TRANSITION | 11 | 111 | 5.958e-09 | 1.54e-06 |
18 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 11 | 111 | 5.958e-09 | 1.54e-06 |
19 | MULTI ORGANISM TRANSPORT | 9 | 68 | 1.143e-08 | 2.66e-06 |
20 | MULTI ORGANISM LOCALIZATION | 9 | 68 | 1.143e-08 | 2.66e-06 |
21 | CELL CYCLE PHASE TRANSITION | 15 | 255 | 1.383e-08 | 3.064e-06 |
22 | RIBOSOME BIOGENESIS | 16 | 308 | 2.585e-08 | 5.428e-06 |
23 | REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 5 | 11 | 2.683e-08 | 5.428e-06 |
24 | CELL CYCLE | 34 | 1316 | 3.277e-08 | 6.352e-06 |
25 | RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION | 13 | 199 | 3.863e-08 | 7.189e-06 |
26 | REGULATION OF RNA STABILITY | 11 | 139 | 6.303e-08 | 1.128e-05 |
27 | RRNA METABOLIC PROCESS | 14 | 255 | 1.008e-07 | 1.738e-05 |
28 | REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 5 | 14 | 1.137e-07 | 1.89e-05 |
29 | REGULATION OF MRNA METABOLIC PROCESS | 10 | 118 | 1.334e-07 | 2.141e-05 |
30 | RNA LOCALIZATION | 12 | 185 | 1.414e-07 | 2.193e-05 |
31 | MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS | 6 | 28 | 1.723e-07 | 2.586e-05 |
32 | CELL CYCLE PROCESS | 29 | 1081 | 1.792e-07 | 2.605e-05 |
33 | PROTEIN LOCALIZATION TO ORGANELLE | 20 | 556 | 1.999e-07 | 2.819e-05 |
34 | REGULATION OF DNA REPLICATION | 11 | 161 | 2.822e-07 | 3.862e-05 |
35 | POSITIVE REGULATION OF GENE EXPRESSION | 38 | 1733 | 3.198e-07 | 4.251e-05 |
36 | REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 7 | 50 | 3.43e-07 | 4.433e-05 |
37 | POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 6 | 33 | 4.876e-07 | 6.132e-05 |
38 | SPLICEOSOMAL COMPLEX ASSEMBLY | 7 | 53 | 5.172e-07 | 6.334e-05 |
39 | NCRNA PROCESSING | 16 | 386 | 5.59e-07 | 6.555e-05 |
40 | REGULATION OF CELL CYCLE | 26 | 949 | 5.635e-07 | 6.555e-05 |
41 | INTERSPECIES INTERACTION BETWEEN ORGANISMS | 21 | 662 | 7.648e-07 | 8.473e-05 |
42 | SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM | 21 | 662 | 7.648e-07 | 8.473e-05 |
43 | MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY | 6 | 37 | 9.929e-07 | 0.0001074 |
44 | POSITIVE REGULATION OF DNA REPLICATION | 8 | 86 | 1.217e-06 | 0.0001257 |
45 | CELL DIVISION | 17 | 460 | 1.197e-06 | 0.0001257 |
46 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 15 | 361 | 1.242e-06 | 0.0001257 |
47 | NCRNA METABOLIC PROCESS | 18 | 533 | 2.069e-06 | 0.0002048 |
48 | REGULATION OF TELOMERE MAINTENANCE | 7 | 67 | 2.62e-06 | 0.000254 |
49 | RNA SECONDARY STRUCTURE UNWINDING | 6 | 44 | 2.859e-06 | 0.0002715 |
50 | REGULATION OF DNA METABOLIC PROCESS | 14 | 340 | 3.161e-06 | 0.0002941 |
51 | MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY | 6 | 45 | 3.274e-06 | 0.0002987 |
52 | NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 12 | 254 | 4.063e-06 | 0.0003636 |
53 | POSITIVE REGULATION OF TELOMERE MAINTENANCE | 6 | 47 | 4.251e-06 | 0.0003663 |
54 | MACROMOLECULE CATABOLIC PROCESS | 24 | 926 | 4.173e-06 | 0.0003663 |
55 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 14 | 354 | 5.03e-06 | 0.0004256 |
56 | CELL CYCLE G2 M PHASE TRANSITION | 9 | 138 | 5.138e-06 | 0.0004269 |
57 | PROTEIN TARGETING | 15 | 406 | 5.232e-06 | 0.0004271 |
58 | MITOTIC NUCLEAR DIVISION | 14 | 361 | 6.292e-06 | 0.0005047 |
59 | DNA METABOLIC PROCESS | 21 | 758 | 6.403e-06 | 0.000505 |
60 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 26 | 1087 | 6.794e-06 | 0.0005269 |
61 | RNA STABILIZATION | 5 | 31 | 8.506e-06 | 0.0006488 |
62 | MACROMOLECULAR COMPLEX ASSEMBLY | 30 | 1398 | 1.056e-05 | 0.0007926 |
63 | SEXUAL REPRODUCTION | 20 | 730 | 1.269e-05 | 0.000937 |
64 | NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 10 | 199 | 1.544e-05 | 0.001123 |
65 | POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 6 | 59 | 1.629e-05 | 0.001166 |
66 | REGULATION OF TRANSFERASE ACTIVITY | 23 | 946 | 1.878e-05 | 0.001324 |
67 | REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 6 | 62 | 2.172e-05 | 0.001509 |
68 | REGULATION OF DNA BIOSYNTHETIC PROCESS | 7 | 94 | 2.506e-05 | 0.001715 |
69 | NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 8 | 131 | 2.798e-05 | 0.001887 |
70 | REGULATION OF RNA SPLICING | 7 | 97 | 3.074e-05 | 0.002043 |
71 | RNA 3 END PROCESSING | 7 | 98 | 3.285e-05 | 0.002153 |
72 | CELLULAR RESPONSE TO DNA DAMAGE STIMULUS | 19 | 720 | 3.529e-05 | 0.002281 |
73 | MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM | 7 | 100 | 3.743e-05 | 0.002386 |
74 | DNA TEMPLATED TRANSCRIPTION TERMINATION | 7 | 101 | 3.991e-05 | 0.002495 |
75 | CELLULAR MACROMOLECULAR COMPLEX ASSEMBLY | 19 | 727 | 4.022e-05 | 0.002495 |
76 | RNA CATABOLIC PROCESS | 10 | 227 | 4.758e-05 | 0.002913 |
77 | ORGANELLE FISSION | 15 | 496 | 5.414e-05 | 0.003246 |
78 | PROTEIN PHOSPHORYLATION | 22 | 944 | 5.442e-05 | 0.003246 |
79 | POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 5 | 45 | 5.514e-05 | 0.003248 |
80 | PEPTIDYL SERINE MODIFICATION | 8 | 148 | 6.678e-05 | 0.003884 |
81 | REGULATION OF CELLULAR RESPONSE TO HEAT | 6 | 76 | 6.95e-05 | 0.003944 |
82 | MULTI ORGANISM REPRODUCTIVE PROCESS | 21 | 891 | 6.933e-05 | 0.003944 |
83 | POSITIVE REGULATION OF RNA SPLICING | 4 | 25 | 7.382e-05 | 0.004089 |
84 | POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 8 | 150 | 7.34e-05 | 0.004089 |
85 | MULTICELLULAR ORGANISM REPRODUCTION | 19 | 768 | 8.34e-05 | 0.004566 |
86 | MRNA SPLICE SITE SELECTION | 4 | 26 | 8.663e-05 | 0.004687 |
87 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 33 | 1805 | 9.156e-05 | 0.004897 |
88 | DNA GEOMETRIC CHANGE | 6 | 81 | 9.935e-05 | 0.005253 |
89 | DNA CATABOLIC PROCESS | 4 | 27 | 0.000101 | 0.005279 |
90 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 21 | 917 | 0.0001039 | 0.005371 |
91 | POSITIVE REGULATION OF TELOMERASE ACTIVITY | 4 | 28 | 0.000117 | 0.00598 |
92 | GAMETE GENERATION | 16 | 595 | 0.0001208 | 0.006107 |
93 | PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION | 4 | 29 | 0.0001347 | 0.006668 |
94 | REPRODUCTION | 26 | 1297 | 0.0001342 | 0.006668 |
95 | CELLULAR MACROMOLECULE LOCALIZATION | 25 | 1234 | 0.0001553 | 0.007608 |
96 | MALE GAMETE GENERATION | 14 | 486 | 0.0001603 | 0.007718 |
97 | ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 13 | 427 | 0.0001609 | 0.007718 |
98 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 16 | 616 | 0.0001793 | 0.008512 |
99 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 7 | 129 | 0.0001872 | 0.008796 |
100 | POSITIVE REGULATION OF MRNA PROCESSING | 4 | 32 | 0.0001996 | 0.009281 |
101 | VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 3 | 13 | 0.0002015 | 0.009281 |
102 | PROTEIN STABILIZATION | 7 | 131 | 0.0002058 | 0.00931 |
103 | REGULATION OF PROTEIN STABILITY | 9 | 221 | 0.0002061 | 0.00931 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA BINDING | 87 | 1598 | 1.183e-46 | 1.099e-43 |
2 | POLY A RNA BINDING | 74 | 1170 | 3.639e-43 | 1.69e-40 |
3 | RIBONUCLEOTIDE BINDING | 64 | 1860 | 9.48e-22 | 2.935e-19 |
4 | ADENYL NUCLEOTIDE BINDING | 55 | 1514 | 1.564e-19 | 3.633e-17 |
5 | NUCLEAR LOCALIZATION SEQUENCE BINDING | 9 | 21 | 9.864e-14 | 1.833e-11 |
6 | HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 31 | 820 | 1.699e-11 | 2.631e-09 |
7 | RNA HELICASE ACTIVITY | 11 | 67 | 2.291e-11 | 3.041e-09 |
8 | SIGNAL SEQUENCE BINDING | 9 | 39 | 6.174e-11 | 7.169e-09 |
9 | PURINE NTP DEPENDENT HELICASE ACTIVITY | 12 | 98 | 9.82e-11 | 1.014e-08 |
10 | POLY PURINE TRACT BINDING | 7 | 19 | 2.198e-10 | 2.042e-08 |
11 | SINGLE STRANDED RNA BINDING | 10 | 69 | 6.851e-10 | 5.786e-08 |
12 | HELICASE ACTIVITY | 13 | 153 | 1.612e-09 | 1.248e-07 |
13 | HEAT SHOCK PROTEIN BINDING | 10 | 89 | 8.75e-09 | 6.253e-07 |
14 | CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 34 | 2.09e-08 | 1.387e-06 |
15 | ATPASE ACTIVITY COUPLED | 16 | 313 | 3.235e-08 | 2.003e-06 |
16 | ATPASE ACTIVITY | 18 | 427 | 8.235e-08 | 4.781e-06 |
17 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 445 | 1.524e-07 | 8.328e-06 |
18 | PROTEIN TRANSPORTER ACTIVITY | 9 | 99 | 3.149e-07 | 1.625e-05 |
19 | UNFOLDED PROTEIN BINDING | 8 | 100 | 3.829e-06 | 0.0001872 |
20 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 25 | 992 | 4.223e-06 | 0.0001961 |
21 | MRNA BINDING | 9 | 155 | 1.318e-05 | 0.0005832 |
22 | GTPASE ACTIVITY | 11 | 246 | 1.728e-05 | 0.0007298 |
23 | CYCLIN BINDING | 4 | 19 | 2.361e-05 | 0.0009537 |
24 | PROTEIN KINASE ACTIVITY | 18 | 640 | 2.502e-05 | 0.0009684 |
25 | DOUBLE STRANDED RNA BINDING | 6 | 64 | 2.61e-05 | 0.0009698 |
26 | HSP90 PROTEIN BINDING | 4 | 27 | 0.000101 | 0.003608 |
27 | TRANSLATION FACTOR ACTIVITY RNA BINDING | 6 | 89 | 0.0001675 | 0.005763 |
28 | POLY A BINDING | 3 | 13 | 0.0002015 | 0.006601 |
29 | AMIDE BINDING | 10 | 272 | 0.000211 | 0.006601 |
30 | SINGLE STRANDED DNA BINDING | 6 | 93 | 0.0002132 | 0.006601 |
31 | TELOMERASE RNA BINDING | 3 | 14 | 0.0002547 | 0.007589 |
32 | GUANYL NUCLEOTIDE BINDING | 12 | 390 | 0.0002614 | 0.007589 |
33 | KINASE ACTIVITY | 19 | 842 | 0.0002713 | 0.007637 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RIBONUCLEOPROTEIN COMPLEX | 46 | 721 | 4.345e-26 | 2.537e-23 |
2 | CATALYTIC STEP 2 SPLICEOSOME | 17 | 89 | 4.44e-18 | 1.296e-15 |
3 | SPLICEOSOMAL COMPLEX | 21 | 172 | 7.09e-18 | 1.38e-15 |
4 | NUCLEOLUS | 37 | 848 | 1.56e-15 | 2.277e-13 |
5 | RIBONUCLEOPROTEIN GRANULE | 14 | 148 | 8.845e-11 | 1.033e-08 |
6 | NUCLEAR PORE | 11 | 77 | 1.101e-10 | 1.071e-08 |
7 | CYTOPLASMIC STRESS GRANULE | 6 | 32 | 4.02e-07 | 3.354e-05 |
8 | NUCLEAR ENVELOPE | 16 | 416 | 1.493e-06 | 0.000109 |
9 | NUCLEAR BODY | 14 | 349 | 4.273e-06 | 0.0002414 |
10 | PRP19 COMPLEX | 4 | 13 | 4.547e-06 | 0.0002414 |
11 | CHROMATOID BODY | 4 | 13 | 4.547e-06 | 0.0002414 |
12 | MICROTUBULE CYTOSKELETON | 26 | 1068 | 4.962e-06 | 0.0002415 |
13 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 5 | 31 | 8.506e-06 | 0.0003821 |
14 | SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX | 6 | 60 | 1.796e-05 | 0.0007493 |
15 | NUCLEOPLASM PART | 18 | 708 | 9.185e-05 | 0.003576 |
16 | ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 3 | 11 | 0.0001178 | 0.0043 |
17 | PROTEIN KINASE COMPLEX | 6 | 90 | 0.0001781 | 0.006118 |
18 | MICROTUBULE ORGANIZING CENTER | 16 | 623 | 0.0002036 | 0.006607 |
19 | CYTOSKELETAL PART | 27 | 1436 | 0.0002788 | 0.008569 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Gap_junction_hsa04540 | 7 | 88 | 1.628e-05 | 0.0004888 | |
2 | Cell_cycle_hsa04110 | 8 | 124 | 1.88e-05 | 0.0004888 | |
3 | Cellular_senescence_hsa04218 | 8 | 160 | 0.0001152 | 0.001904 | |
4 | Oocyte_meiosis_hsa04114 | 7 | 124 | 0.0001464 | 0.001904 | |
5 | p53_signaling_pathway_hsa04115 | 4 | 68 | 0.003501 | 0.03642 | |
6 | Adherens_junction_hsa04520 | 4 | 72 | 0.0043 | 0.03727 | |
7 | FoxO_signaling_pathway_hsa04068 | 5 | 132 | 0.007378 | 0.05481 | |
8 | Apoptosis_hsa04210 | 5 | 138 | 0.008852 | 0.05754 | |
9 | Phagosome_hsa04145 | 5 | 152 | 0.01306 | 0.07543 | |
10 | Tight_junction_hsa04530 | 5 | 170 | 0.02021 | 0.1051 | |
11 | Hippo_signaling_pathway_multiple_species_hsa04392 | 2 | 29 | 0.02876 | 0.1359 | |
12 | Wnt_signaling_pathway_hsa04310 | 4 | 146 | 0.04533 | 0.1964 | |
13 | Hippo_signaling_pathway_hsa04390 | 4 | 154 | 0.05322 | 0.2129 | |
14 | VEGF_signaling_pathway_hsa04370 | 2 | 59 | 0.1016 | 0.3641 | |
15 | PI3K_Akt_signaling_pathway_hsa04151 | 6 | 352 | 0.105 | 0.3641 | |
16 | MAPK_signaling_pathway_hsa04010 | 5 | 295 | 0.1346 | 0.4376 | |
17 | mTOR_signaling_pathway_hsa04150 | 3 | 151 | 0.1608 | 0.4919 | |
18 | TGF_beta_signaling_pathway_hsa04350 | 2 | 84 | 0.1794 | 0.5142 | |
19 | cGMP_PKG_signaling_pathway_hsa04022 | 3 | 163 | 0.1879 | 0.5142 | |
20 | NF_kappa_B_signaling_pathway_hsa04064 | 2 | 95 | 0.2159 | 0.5614 | |
21 | HIF_1_signaling_pathway_hsa04066 | 2 | 100 | 0.2328 | 0.5764 | |
22 | Regulation_of_actin_cytoskeleton_hsa04810 | 3 | 208 | 0.2969 | 0.6962 | |
23 | Calcium_signaling_pathway_hsa04020 | 2 | 182 | 0.4978 | 0.9588 | |
24 | Focal_adhesion_hsa04510 | 2 | 199 | 0.5457 | 0.9783 | |
25 | Rap1_signaling_pathway_hsa04015 | 2 | 206 | 0.5644 | 0.9783 | |
26 | Endocytosis_hsa04144 | 2 | 244 | 0.6565 | 1 |